Silence Therapeutics plc
SLN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$36 | -$50 | -$50 | -$62 |
| Dep. & Amort. | $1 | $0 | $1 | $1 |
| Deferred Tax | $1 | $0 | $1 | $6 |
| Stock-Based Comp. | $13 | $13 | $13 | $12 |
| Change in WC | -$33 | -$12 | -$19 | $52 |
| Other Non-Cash | -$13 | $9 | -$1 | $0 |
| Operating Cash Flow | -$68 | -$39 | -$57 | $9 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$139 | -$21 | -$20 | $0 |
| Inv. Sales/Matur. | $0 | $36 | $0 | $13 |
| Other Inv. Act. | $117 | $1 | -$0 | -$0 |
| Investing Cash Flow | -$22 | $16 | -$20 | $12 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$0 | $0 | -$0 |
| Stock Issued | $142 | $25 | $53 | $42 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$0 |
| Financing Cash Flow | $142 | $25 | $53 | $41 |
| Forex Effect | $0 | -$3 | -$8 | -$0 |
| Net Chg. in Cash | $53 | -$1 | -$33 | $62 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $69 | $55 | $99 | $37 |
| End Cash | $121 | $54 | $66 | $99 |
| Free Cash Flow | -$68 | -$39 | -$58 | $7 |